Verastem reported $-21373000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
AstraZeneca AZN:LN 292568.43M 24571.33M
Curis CRIS:US $ -15.02M 0.08M
Cytokinetics CYTK:US $ -9.47M 67.05M
Epizyme EPZM:US $ -28.52M 21.1M
Gilead Sciences GILD:US $ 2585M 837M
Laboratory Of America LH:US $ 751.4M 111.8M
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Verastem VSTM:US $ -21.37M 4.42M
YTE INCY:US $ 276.8M 132.69M
Ziopharm Oncology ZIOP:US $ -8.68M 0.28M